ALS ACCESS (@brainmatters10) header
ALS ACCESS (@brainmatters10) profile picture

ALS ACCESS

@brainmatters10

Fighting for a cure for ALS/MND/ and it’s variants. Fighting daily for many years, for ALS drug access. Sod1 Gene carrier. Animals are my Love!!

Joined June 2018
  • Tweets7.7K
  • Following2.2K
  • Followers2.2K
601Media
Photo by ALS ACCESS (@brainmatters10)Photo by ALS ACCESS (@brainmatters10)Photo by ALS ACCESS (@brainmatters10)Photo by ALS ACCESS (@brainmatters10)Photo by ALS ACCESS (@brainmatters10)Photo by ALS ACCESS (@brainmatters10)Photo by ALS ACCESS (@brainmatters10)Photo by ALS ACCESS (@brainmatters10)Photo by ALS ACCESS (@brainmatters10)Photo by ALS ACCESS (@brainmatters10)
Image from ALS ACCESS (@brainmatters10)
115
ir.brainstorm-cell.com/2025-…

BrainStorm Announces New Survival Data from Expanded Access Program Cohort: Remarkably 90% of ALS...

BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapies for neurodegenerative diseases, today announced new survival data from 10 participants in its...

ir.brainstorm-cell.com
1
1
105
One is magical. The other is real... for now. The #rhino may not be a creature of myth, but its future is just as uncertain! While unicorns live in fantasy, #rhinos are fighting #extinction—right here, right now. Let’s not let the real become imaginary! #StopRhinoPoaching 🦏🆘️
Image from Sue Spurgin (@SueSpurgin)
5
20
3
50
1,158
please look at @BrainstormCell
10
Please make @CoyaTx @BrainstormCell your focus. ALS needs a hero!
1
2
36
Matt Bellina @BellinaMatthew was wheelchair-bound with ALS. Then he got NurOwn under @realDonaldTrump Right to Try law. After 7 treatments, he stood up. Swallowed again. Breathed on his own. His ALS reversed. Why did the prior FDA ignore this “first sign of promise”? #ALS #NurOwn @VPrasadMDMPH @DrMakaryFDA @RobertKennedyJr
BioSpace (@biospace) profile pictureBioSpace@biospace4 Jun 2025
The FDA plans to “rapidly make available” rare disease drugs and make use of surrogate endpoints to get promising medicines to patients before they clear the traditional efficacy bar for authorization, Prasad said Tuesday. #fda #raredisease #biospace hubs.li/Q03qF7nP0
FDA’s Prasad Vows To Make Rare Disease Drugs Available at ‘First Sign of Promise’

FDA’s Prasad Vows To Make Rare Disease Drugs Available at ‘First Sign of Promise’

The FDA plans to “rapidly make available” rare disease drugs and make use of surrogate endpoints to get promising medicines to patients before they clear the traditional efficacy bar for authorizat...

biospace.com
1
11
22
778
@Cylebo Please attend!
1
1
3
152
@BrainstormCell please sign up!!
1
123

No more items